112 related articles for article (PubMed ID: 36623376)
1. Dye-cored polylysine dendrimer as luminescent nanoplatform for imaging-guided anticancer drug delivery.
Zhu P; Younis MR; Ma G; Zhang Q; An R; Wang K; Dong J
Colloids Surf B Biointerfaces; 2023 Feb; 222():113130. PubMed ID: 36623376
[TBL] [Abstract][Full Text] [Related]
2. Linear-Dendritic Polymer-Platinum Complexes Forming Well-Defined Nanocapsules for Acid-Responsive Drug Delivery.
Liu K; Xiang J; Wang G; Xu H; Piao Y; Liu X; Tang J; Shen Y; Zhou Z
ACS Appl Mater Interfaces; 2021 Sep; 13(37):44028-44040. PubMed ID: 34499483
[TBL] [Abstract][Full Text] [Related]
3. PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy.
Pan D; She W; Guo C; Luo K; Yi Q; Gu Z
Biomaterials; 2014 Dec; 35(38):10080-92. PubMed ID: 25263685
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
5. Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker.
Mehta D; Leong N; McLeod VM; Kelly BD; Pathak R; Owen DJ; Porter CJH; Kaminskas LM
Mol Pharm; 2018 Oct; 15(10):4568-4576. PubMed ID: 30107748
[TBL] [Abstract][Full Text] [Related]
6. Core-shell tecto dendrimers formed via host-guest supramolecular assembly as pH-responsive intelligent carriers for enhanced anticancer drug delivery.
Wang J; Li D; Fan Y; Shi M; Yang Y; Wang L; Peng Y; Shen M; Shi X
Nanoscale; 2019 Nov; 11(46):22343-22350. PubMed ID: 31728477
[TBL] [Abstract][Full Text] [Related]
7. Dendrimer-assisted formation of fluorescent nanogels for drug delivery and intracellular imaging.
Gonçalves M; Maciel D; Capelo D; Xiao S; Sun W; Shi X; Rodrigues J; Tomás H; Li Y
Biomacromolecules; 2014 Feb; 15(2):492-9. PubMed ID: 24432789
[TBL] [Abstract][Full Text] [Related]
8. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
9. Glutaryl Polyamidoamine Dendrimer for Overcoming Cisplatin-Resistance of Breast Cancer Cells.
Xu X; Li Y; Lu X; Sun Y; Luo J; Zhang Y
J Nanosci Nanotechnol; 2018 Oct; 18(10):6732-6739. PubMed ID: 29954488
[TBL] [Abstract][Full Text] [Related]
10. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
11. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
13. A Dual-Responsive Platform Based on Antifouling Dendrimer-CuS Nanohybrids for Enhanced Tumor Delivery and Combination Therapy.
Xiong Z; Wang Y; Zhu W; Ouyang Z; Zhu Y; Shen M; Xia J; Shi X
Small Methods; 2021 Jun; 5(6):e2100204. PubMed ID: 34927910
[TBL] [Abstract][Full Text] [Related]
14. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).
Chang Y; Meng X; Zhao Y; Li K; Zhao B; Zhu M; Li Y; Chen X; Wang J
J Colloid Interface Sci; 2011 Nov; 363(1):403-9. PubMed ID: 21821262
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Dendrimer-Entrapped Gold Nanoparticles Conjugated with Doxorubicin for pH-Responsive Drug Delivery and Targeted Computed Tomography Imaging.
Zhu J; Wang G; Alves CS; Tomás H; Xiong Z; Shen M; Rodrigues J; Shi X
Langmuir; 2018 Oct; 34(41):12428-12435. PubMed ID: 30251859
[TBL] [Abstract][Full Text] [Related]
16. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers.
Zhang M; Guo R; Kéri M; Bányai I; Zheng Y; Cao M; Cao X; Shi X
J Phys Chem B; 2014 Feb; 118(6):1696-706. PubMed ID: 24467521
[TBL] [Abstract][Full Text] [Related]
17. Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines.
Haririan I; Alavidjeh MS; Khorramizadeh MR; Ardestani MS; Ghane ZZ; Namazi H
Int J Nanomedicine; 2010 Feb; 5():63-75. PubMed ID: 20161988
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy.
Fu B; Dang M; Tao J; Li Y; Tang Y
J Colloid Interface Sci; 2020 Jun; 570():197-204. PubMed ID: 32151829
[TBL] [Abstract][Full Text] [Related]
19. Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy.
Hu Q; Wang Y; Xu L; Chen D; Cheng L
Int J Nanomedicine; 2020; 15():2751-2764. PubMed ID: 32368053
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
